Commonwealth Retirement Investments LLC increased its holdings in The Allstate Co. (NYSE:ALL – Free Report) by 9.0% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 5,813 shares of the insurance provider’s stock after buying an additional 479 shares during the period. Commonwealth Retirement Investments LLC’s holdings in Allstate were worth $1,102,000 as of its most recent filing with the SEC.
A number of other institutional investors have also modified their holdings of the business. Northwest Investment Counselors LLC bought a new stake in Allstate in the 3rd quarter valued at about $28,000. Catalyst Capital Advisors LLC bought a new position in shares of Allstate during the 3rd quarter valued at about $29,000. Versant Capital Management Inc grew its position in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after buying an additional 78 shares during the last quarter. Family Firm Inc. acquired a new position in shares of Allstate in the 2nd quarter worth $38,000. Finally, MCF Advisors LLC increased its stake in Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Allstate Stock Performance
NYSE:ALL traded up $0.43 during mid-day trading on Tuesday, hitting $197.95. 134,408 shares of the company’s stock traded hands, compared to its average volume of 1,543,858. The Allstate Co. has a 12 month low of $129.17 and a 12 month high of $201.00. The firm has a market capitalization of $52.42 billion, a price-to-earnings ratio of 12.79, a price-to-earnings-growth ratio of 1.83 and a beta of 0.48. The firm has a 50 day moving average of $189.26 and a two-hundred day moving average of $176.05. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43.
Insider Buying and Selling
In other news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Toohey sold 16,682 shares of the company’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the sale, the executive vice president now directly owns 4,873 shares in the company, valued at approximately $877,968.41. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 192,530 shares of company stock valued at $34,967,665 over the last three months. 1.80% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Several analysts have issued reports on the stock. The Goldman Sachs Group boosted their target price on shares of Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a research note on Thursday, August 15th. Roth Mkm reaffirmed a “buy” rating and issued a $200.00 target price on shares of Allstate in a research report on Wednesday, August 14th. Jefferies Financial Group lifted their price target on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a report on Friday. Piper Sandler boosted their price target on Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research note on Friday, August 16th. Finally, Keefe, Bruyette & Woods raised their price objective on shares of Allstate from $222.00 to $225.00 and gave the company an “outperform” rating in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Allstate has an average rating of “Moderate Buy” and an average target price of $212.56.
Read Our Latest Stock Analysis on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- How to Use the MarketBeat Excel Dividend Calculator
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- With Risk Tolerance, One Size Does Not Fit All
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.